The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients
Oral Diseases · 2024-11 · 30 (8) · 5160-5174
DOI: 10.1111/odi.14931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 19.03.2024. Verfasst von Yao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Liraglutide, Mesenchymal Stem Cells, Osteogenesis, Rats, Wistar. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University, Beijing Hospitals Authority Youth Programme.
Abstract (Originalsprache)
Objectives
To investigate the effect of liraglutide on osteogenesis in human alveolar bone marrow mesenchymal stem cells (BMSCs) and the influence of liraglutide on implant–bone integration in rats with T2DM. Subjects and methods Extracting BMSCs from the alveoli of diabetic patients treated with insulin. BMSCs were treated with different concentrations of liraglutide. Osteogenesis and the underlying mechanism were investigated via ALP detection, ALP staining, Alizarin Red S staining, Western blotting, and RT‐PCR. Liraglutide was given to Wistar and GK rats after implantation, and new bone formation around the implants was analyzed via micro‐CT. Implant–bone integration in rats was investigated via toluidine blue staining.
Results
Liraglutide enhanced osteogenesis in BMSCs via the BMP2/Smad/Runx2 signaling pathway. The optimal concentration of liraglutide that promoted osteogenesis was 10 −8 mol/L. At concentrations higher than 10 −7 mol/L, liraglutide had a negative effect on BMSCs. At a concentration of 10 −8 mol/L liraglutide, BMSCs and diabetes mellitus–bone marrow stromal cells (DM‐BMSCs) showed optimal osteogenesis. Liraglutide promoted implant–bone integration and new bone formation in Wistar and GK rats.
Conclusions
Liraglutide not only promotes osteogenesis of BMSCs in normoglycemic individuals but also enhances osteogenesis of BMSCs in diabetic patients treated with insulin and enhances osseointegration in rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China.
ORCID-Profile: Jun Li
Förderung
- Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University
- Beijing Hospitals Authority Youth Programme
Zitieren
APA
Wang, Y., Sun, Y., Yang, B., Li, J., & Liang, C. (2024). The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients. Oral Diseases, 30(8), 5160-5174. https://doi.org/10.1111/odi.14931
Vancouver
Wang Y, Sun Y, Yang B, Li J, Liang C. The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients. Oral Diseases. 2024;30(8):5160-5174. doi:10.1111/odi.14931
BibTeX
@article{Wang2024,
author = {Wang, Yao and Sun, Yujie and Yang, Bo and Li, Jun and Liang, Chao},
title = {The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients},
journal = {Oral Diseases},
year = {2024},
volume = {30},
number = {8},
pages = {5160--5174},
doi = {10.1111/odi.14931}
}
EUVIMED